Congress mulling whether to move human growth hormone to Schedule III
A nonprofit group concerned over short stature in kids opposes legislation now under consideration in Congress that would move human growth hormone into Schedule III of the Controlled Substances Act.
Should human growth hormone be classified as a Schedule III controlled substance? That's what Congress is set to vote on this week. The House Bill 4911, claiming that they could hurt children's health, such as by affecting their frequency of doctor visits or the cost of copays.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
Related Content
